Page 18 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In U11248 Today - Breaking & Trending Today
The risk is higher when immunotherapy comes within 3 months of cranial radiotherapy. The study was published as a preprint and has not yet been peer reviewed. ....
Remission at 6 months was recorded in 73.1% of rituximab-treated patients and 40.1% of cyclophosphamide-treated patients in a multicenter target trial emulation. ....